A significant advance in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in various forms of cancer, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research